Yale Podnos has sold TOI and made no open-market buys since Jun 2026

Yale D. Podnos, MD, MPH, FACS, is an individual and serves as Chief Medical Officer and President at The Oncology Institute, Inc. (TOI), a leading value-based oncology group in the United States.( In this role, he oversees clinical strategy and operations across TOI’s network, with a focus on value-based oncology care, quality improvement, and patient outcomes.( He is also a frequent speaker on value-based specialty care and social determinants of health, including representing TOI on national panels such as the APG Spring Conference.(

Podnos is a surgical oncologist with significant prior leadership experience, including serving as Chief Medical Officer at West Hills Hospital and Medical Center, and as Chairman and Medical Director for Surgical Oncology at UNC REX Healthcare.( He has also consulted for medical technology companies such as Ethicon, Inc. and SurgRx.( A native of Southern California, he completed a biology undergraduate degree at New York University, earned his MD from the University of California, Irvine School of Medicine, and obtained a Master’s in Health Administration/Public Health from the Harvard T.H. Chan School of Public Health.( He further completed a fellowship in Surgical Oncology at City of Hope National Cancer Center, underpinning his career at the intersection of oncology, health systems leadership, and value-based care.(

Written by Perplexity from public sources.